Comparison of anatomical and functional changes in patients with type 1 and type 2 PCV at 3 months
| Type 1 PCV (n=16) | Type 2 PCV (n=13) | p Value | |
|---|---|---|---|
| Complete polyp regression (%) | 13 (81.2) | 4 (30.8) | 0.020* |
| Partial polyp regression (%) | 3 (18.8) | 7 (53.8) | |
| No regression (%) | 0 (0) | 2 (15.4) | |
| Dry macula (%) | 11 (69) | 5 (39) | 0.103* |
| Changes in BCVA (logMAR)† | −0.36±0.30 | −0.08±0.19 | 0.036‡ |
| Changes in largest polyp dimeter (μm)† | −197.5±150.6 | −96.9±107.1 | 0.083‡ |
| Changes in largest PED height (μm)† | −248.7±251.1 | −124.5±138.9 | 0.110‡ |
| Changes in CMT (μm)† | −191.9±121.8 | −163.2±91.4 | 0.650‡ |
| Changes in subfoveal CT (μm)† | −20.4±24.1 | −39.8±23.2 | 0.040‡ |
*p Value using Fisher's exact test.
†Data are presented as mean±SD and number (%).
‡p Value using the Mann–Whitney test.
BCVA, best-corrected visual acuity; CMT, central macular thickness; CT, choroidal thickness; logMAR, logarithm of the minimum angle of resolution; PCV, polypoidal choroidal vasculopathy; PED, pigment epithelial detachment.